Not Yet Recruiting INTERVENTIONAL NCT06916325

Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion

DeLIVER Trial: A Prospective, Multi-Center, Single-Arm, Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion

Sponsor: XVIVO Perfusion

Conditions Liver Transplant Surgery Liver Transplantation

Interventions dual hypothermic oxygenated perfusion (DHOPE)

Updated 2 times since 2025 Last updated: Apr 16, 2026 Started: Jan 1, 2027 Primary completion: Oct 1, 2028 Completion: Apr 1, 2033

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06916325, this observational or N/A phase trial focuses on Liver Transplant Surgery and Liver Transplantation and remains actively recruiting participants. Sponsored by XVIVO Perfusion, it has been updated 2 times since 2027, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Apr 21, 2026 — Present [daily]

Not Yet Recruiting

Phase: NA → None
May 2025 — Apr 2026 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

The purpose of this clinical study is to confirm the safety and effectiveness of dual hypothermic oxygenated perfusion (DHOPE) using the Liver Assist to preserve deceased donor livers for transplantation.

Contact Information

Sponsor contact:

XVIVO Perfusion

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.